EVALUATION OF THE ROLE OF THE CLOTS-AF SCORE IN PREDICTING LEFT ATRIAL APPENDAGE THROMBUS IN PATIENTS WITH ATRIAL FIBRILLATION
Main Article Content
Abstract
Objective: To evaluate the role of the CLOTS-AF score in predicting left atrial appendage thrombus (LAAT) in patients with atrial fibrillation (AF). Methods: A cross-sectional descriptive study was conducted on 149 AF patients undergoing transesophageal echocardiography (TEE). Clinical and paraclinical characteristics were compared between groups with and without LAAT. Receiver Operating Characteristic (ROC) curve analysis was used to assess the predictive performance of the CLOTS-AF score. Results: Of 149 patients, 18 (12.1%) had LAAT on TEE. Predictors of LAAT included: Shorter duration of anticoagulant therapy (OR 0.733, 95% CI 0.593–0.907, p=0.004), heart failure with LVEF <50% (OR 4.267, 95% CI 1.455–12.515, p=0.008), use of mineralocorticoid receptor antagonists (MRA) (OR 3.532, 95% CI 1.223–10.199, p=0.02) and use of furosemide (OR 3.353, 95% CI 1.111–10.119, p=0.032). In multivariate regression, shorter anticoagulant therapy duration remained an independent predictor (OR 0.648, 95% CI 0.491–0.854, p=0.002). The CLOTS-AF score demonstrated superior predictive ability with an AUC of 0.696 (95% CI 0.562–0.830, p=0.007). At a cutoff of ≥3.5, it achieved a sensitivity of 50% and specificity of 82.4%, outperforming other scores at similar thresholds. Conclusion: The CLOTS-AF score is a useful tool for predicting LAAT in AF patients, particularly in settings where routine TEE is not feasible, aiding clinical decision-making. However, its sensitivity at the optimal cutoff is limited, necessitating further research to improve and validate it in larger populations.
Article Details
Keywords
Atrial fibrillation, left atrial appendage thrombus, transesophageal echocardiography.
References
2. Wyse, D. G., Van Gelder, I. C., Ellinor, P. T., et al. (2014). Lone Atrial Fibrillation: Does It Exist? Journal of the American College of Cardiology, 63(17), 1715–1723. https://doi.org/ 10.1016/j.jacc.2014.01.023
3. Pisters, R., Lane, D. A., Marin, F., et al. (2012). Stroke and Thromboembolism in Atrial Fibrillation: Systematic Review of Stroke Risk Factors and Risk Stratification Schema. Circulation Journal, 76(10), 2289–2304. https://doi.org/ 10.1253/circj.CJ-12-0633
4. Lip, G. Y. H., Nieuwlaat, R., Pisters, R., et al. (2010). Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach: The Euro Heart Survey on Atrial Fibrillation. Chest, 137(2), 263–272. https://doi. org/10.1378/chest.09-1584
5. Szymanski, F. M., Lip, G. Y. H., Filipiak, K. J., et al. (2015). Stroke Risk Factors Beyond the CHA₂DS₂-VASc Score: Can We Improve Our Identification of “High Stroke Risk” Patients With Atrial Fibrillation? American Journal of Cardiology, 116(11), 1781–1788. https://doi.org/10.1016/ j.amjcard.2015.08.038
6. Vinereanu, D., Lopes, R. D., Mulder, H., et al. (2017). Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. Stroke, 48(12), 3266–3273. https://doi.org/10.1161/ STROKEAHA.117.017574
7. Zhuang, J., Wang, Y., Tang, K., et al. (2012). Association Between Left Atrial Size and Atrial Fibrillation Recurrence After Single Circumferential Pulmonary Vein Isolation: A Systematic Review and Meta-analysis of Observational Studies. Europace, 14(5), 638–645. https://doi.org/10. 1093/europace/eur364
8. You, J. J., Singer, D. E., Howard, P. A., et al. (2012). Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141(2 Suppl), e531S–e575S. https://doi.org/10.1378/chest.11-2304
9. Segan, L., et al. (2023). Identifying Patients at High Risk of Left Atrial Appendage Thrombus Before Cardioversion: The CLOTS-AF Score. Journal of the American Heart Association, 12(12), e029259. https://doi.org/10.1161/JAHA. 122.029259
10. Esteve-Pastor, M. A., Roldán, V., Rivera-Caravaca, J. M., et al. (2019). The Use of Biomarkers in Clinical Management Guidelines. Thrombosis and Haemostasis, 119(12), 1901–1919. https://doi.org/10.1055/s-0039-1693465